Mirae Asset Global Investments’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
HWAM
BWCS
BWM
AA
SFWA
KWA
PAM
LSA
PFSRSONJ
Mirae Asset Global Investments's ALT Position: Q2 2026 in Review
Mirae Asset Global Investments increased its Altimmune (ALT) stake by 33% in Q2 2026, buying an estimated $6.47K and bringing the position to 8,698 shares worth $26.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1459.
Mirae Asset Global Investments first reported a position in ALT in Q1 2023 and has held it in 11 quarters since. The position peaked at $271K in Q1 2024. 39 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Mirae Asset Global Investments held 8,698 shares of Altimmune worth $26.4K as of Q2 2026.
- Mirae Asset Global Investments bought 2,166 Altimmune shares in Q2 2026, an estimated $6.47K.
- Altimmune made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1459 holding.
- Mirae Asset Global Investments first reported a position in Altimmune in Q1 2023 and has held it in 11 quarters since.
- Mirae Asset Global Investments's Altimmune position peaked at $271K in Q1 2024.
- 39 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.